These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Relationship between length of time and contamination in open intravenous solutions. Amonsen S; Gren JE Nurs Res; 1978; 27(6):372-4. PubMed ID: 251249 [TBL] [Abstract][Full Text] [Related]
7. Control of infections from intravenous infusions. Med Lett Drugs Ther; 1973 Dec; 15(26):105-7. PubMed ID: 4203094 [No Abstract] [Full Text] [Related]
8. The container size/volume relationship in particulate contamination. Green H; McNelis J; Steinman S J Parenter Drug Assoc; 1979; 33(6):319-25. PubMed ID: 261582 [No Abstract] [Full Text] [Related]
14. Particulate contamination in New Zealand intravenous solutions. Passl WJ; Waring JM N Z Med J; 1980 Mar; 91(655):177-9. PubMed ID: 6929987 [TBL] [Abstract][Full Text] [Related]
15. A model particulate research laboratory: I. Characterization of glass for parenteral products. Scothorn WW; Roseman TJ; Hamlin WE Bull Parenter Drug Assoc; 1976; 30(3):105-17. PubMed ID: 1268429 [No Abstract] [Full Text] [Related]
16. [Danger from the bottle?]. MMW Munch Med Wochenschr; 1979 Apr; 121(14):468-70. PubMed ID: 107430 [No Abstract] [Full Text] [Related]
17. Quantitative determination of chemicals leached from rubber stoppers into parenteral solutions. Danielson JW; Oxborrow GS; Placencia AM J Parenter Sci Technol; 1984; 38(3):90-3. PubMed ID: 6747780 [No Abstract] [Full Text] [Related]
18. Particulate contamination from siliconized rubber stoppers--a statistical evaluation. Li LC; Parasrampuria J; Tian Y J Parenter Sci Technol; 1993; 47(5):270-3. PubMed ID: 8263665 [TBL] [Abstract][Full Text] [Related]
19. [Insoluble contaminants in large-volume parenteral solutions. III. Effect of drug containers and sterilization]. Pawlaczyk J; Nowacka D Acta Pol Pharm; 1983; 40(2):199-206. PubMed ID: 6659998 [No Abstract] [Full Text] [Related]